merged_abortion-pill-ella.txt
<other>First, I will analyze the article to find the relevant information for each question.</other>
<question_number>1</question_number>
<answer>N/A</answer>
<other>The article does not provide a direct comparison of completion rates between patients who received ulipristal acetate plus misoprostol versus those who received mifepristone plus misoprostol.</other>
<question_number>2</question_number>
<answer>N/A</answer>
<other>The article does not specify the exact milligram dosage of ulipristal acetate prescribed by Dr. Gomperts in Europe for use as an alternative to mifepristone.</other>
<question_number>3</question_number>
<answer>N/A</answer>
<other>The article does not mention any state's attorney general filing litigation challenging the use of Ella as emergency contraception following the study's publication.</other>
<question_number>4</question_number>
<answer>N/A</answer>
<other>The article does not provide information on the percentage of women who reported severe side effects from the ulipristal acetate and misoprostol combination.</other>
<question_number>5</answer>
<answer>N/A</answer>
<other>The article does not specify what should replace Ella in the required insurance coverage under the Affordable Care Act according to Project 2025's policy recommendations.</other>
<question_number>6</question_number>
<answer>N/A</answer>
<other>The article does not mention the number of days after the Supreme Court's 2022 decision that Dr. Winikoff began her research on ulipristal acetate as an alternative.</other>
<question_number>7</question_number>
<answer>To make it clear that Plan B acts only before fertilization, will not work if you're already pregnant, and will not affect an existing pregnancy.</answer>
<other>The FDA changed Plan B's label language in 2022 to clarify its mechanism of action based on scientific evidence.</other>
<question_number>8</question_number>
<answer>N/A</answer>
<other>The article does not specify which pharmaceutical company funded the Mexico City portion of the ulipristal acetate study.</other>
<question_number>9</question_number>
<answer>N/A</answer>
<other>The article does not mention the dosing interval determined by the researchers between the administration of ulipristal acetate and misoprostol in the study protocol.</other>
<question_number>10</question_number>
<answer>3</answer>
<other>Three states joined as plaintiffs in the revived federal lawsuit against the FDA after the Supreme Court rejected the initial case.</other>
<question_number>11</question_number>
<answer>60mg</answer>
<other>The Mexico City researchers used a 60mg dose of ulipristal acetate in their study, which is double the 30mg dose in Ella.</other>
<question_number>12</question_number>
<answer>N/A</answer>
<other>The article does not specify what legal action Students for Life of America would consider regarding the FDA-approved label change for Plan B One-Step.</other>
<question_number>13</question_number>
<answer>The claim that Ella acts as an abortifacient.</answer>
<other>The Texas attorney general's lawsuit against the New York doctor suggests that the legal argument would likely focus on Ella's mechanism of action as an abortifacient.</other>
<question_number>14</question_number>
<answer>N/A</answer>
<other>The article does not provide information on the percentage of pregnancies terminated solely by using the standard 30mg dose of Ella in the NEJM Evidence study.</other>
<question_number>15</question_number>
<answer>Facilitating an abortion.</answer>
<other>Misoprostol's medical use, other than facilitating abortion, is not mentioned in the context of the revived federal lawsuit against the FDA.</other>
<question_number>16</question_number>
<answer>The Supreme Court rejected the initial lawsuit, ruling that the initial plaintiffs lacked standing to sue.</answer>
<other>Mary Ziegler's comments and the pilot program in Washington State do not directly relate to the Supreme Court's action on the revived lawsuit.</other>
<question_number>17</question_number>
<answer>N/A</answer>
<other>The article does not mention the name of the telemedicine organization founded by the Dutch physician studying ulipristal acetate as a weekly birth control pill.</other>
<question_number>18</answer>
<answer>To stop or delay ovulation.</answer>
<other>The FDA label's primary mechanism of action for the drug used in the Washington State pilot program is to stop or delay ovulation.</other>
<question_number>19</question_number>
<answer>Dr. Beverly Winikoff</answer>
<other>Dr. Beverly Winikoff is the lead author of the Gynuity Health Projects study and is also researching low doses of mifepristone for birth control.</other>
<question_number>20</question_number>
<answer>Progesterone</answer>
<other>Progesterone is the hormone blocked by both mifepristone and the higher dose of ulipristal acetate, which would be directly affected if the revived lawsuit against the FDA succeeds.</other>